Asia Pacific Region was the largest of Idexx Laboratories Inc /De’s 3 reported lines in fiscal 2009, at $116.95M — 61% of $191.85M.
| Geography | FY 2009 |
|---|---|
| Asia Pacific Region | $116.95M |
| Europe, The Middle East & Africa | $62.48M |
| Americas | $12.42M |
| Total | $191.85M |
In fiscal 2009, which ended December 31, 2009, the 3 regions Idexx Laboratories Inc /De reported in this breakdown added up to $191.85M. Asia Pacific Region was the largest region, at $116.95M or 61.0% of the total, followed by Europe, The Middle East & Africa ($62.48M, 32.6%) and Americas ($12.42M, 6.5%). Together, the two largest regions made up 93.5% of this total.
This breakdown covers every fiscal year from 2009 to 2009, as reported in Idexx Laboratories Inc /De's annual filings.
Idexx Vetlab Consumables was the largest of Idexx Laboratories Inc /De’s 8 reported lines in fiscal 2025, at $1.50B — 35% of $4.30B.
| Segment | FY 2011 | FY 2012 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Idexx Vetlab Consumables | $1.06B | $1.19B | $1.30B | $1.50B | ||||||||||
| Cag Diagnostics Recurring Revenue | — | — | — | — | ||||||||||
| Service Revenue | — | — | — | — | ||||||||||
| Reference Laboratory Diagnostic & Consulting Services | $1.18B | $1.28B | $1.34B | $1.42B | ||||||||||
| Vetlab Consumables | — | — | — | — | ||||||||||
| Rapid Assay Products | $313.67M | $344.49M | $359.75M | $348.95M | ||||||||||
| Veterinary Software, Services, & Diagnostic Imaging Systems: | — | $279.33M | $312.62M | $345.88M | ||||||||||
| Veterinary Software, Services & Diagnostic Imaging Systems: | $251.19M | — | — | — | ||||||||||
| Veterinary Software, Services & Diagnostic Imaging Systems | — | — | — | — | ||||||||||
| Recurring Revenue | $180.97M | $214.60M | $250.36M | $276.34M | ||||||||||
| Cag Diagnostics Capital - Instruments | $147.33M | $137.60M | $131.93M | $200.21M | ||||||||||
| Cag Diagnostic Capital - Instruments | — | — | — | — | ||||||||||
| Cag Diagnostic Captail - Vetlab Instruments | — | — | — | — | ||||||||||
| Cag Diagnostics Services & Accessories | $111.26M | $124.05M | $130.37M | $137.42M | ||||||||||
| Cag Diagnostics Service & Accessories | — | — | — | — | ||||||||||
| Customer Information Managment & Digital Imaging Systems | — | — | — | — | ||||||||||
| Systems & Hardware | $70.21M | $64.73M | $62.27M | $69.54M | ||||||||||
| Vetlab Service & Accessories | — | — | — | — | ||||||||||
| Total | $3.31B | $3.63B | $3.89B | $4.30B |
In fiscal 2025, which ended December 31, 2025, the 8 segments Idexx Laboratories Inc /De reported in this breakdown added up to $4.30B. That was up 10.6% from $3.89B in fiscal 2024. Idexx Vetlab Consumables was the largest segment, at $1.50B or 34.8% of the total, followed by Reference Laboratory Diagnostic & Consulting Services ($1.42B, 33.1%) and Rapid Assay Products ($348.95M, 8.1%). Together, the two largest segments made up 67.9% of this total.
Compared with fiscal 2024, Cag Diagnostics Capital - Instruments grew the fastest, rising 51.8% to $200.21M. Rapid Assay Products fell the most, down 3.0% to $348.95M.
Veterinary Software, Services, & Diagnostic Imaging Systems: was first reported as a separate segment in fiscal 2023. The table also keeps 10 segments that Idexx Laboratories Inc /De no longer reports, so earlier years can still be read on their original basis; use "Show 10 discontinued" beneath the table to see them. This breakdown covers 14 fiscal years between 2011 and 2025, as reported in Idexx Laboratories Inc /De's annual filings.
Cag was the largest of Idexx Laboratories Inc /De’s 3 reported lines in fiscal 2025, at $1.50B — 82% of $1.83B.
| Statement Business Segments | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cag | $1.18B | $1.28B | $1.34B | $1.50B | ||||||||||||
| Cag Segment Revenue | — | — | — | — | ||||||||||||
| Lpd Segment Revenue | — | — | — | — | ||||||||||||
| Lpd | $122.61M | $121.66M | $122.06M | $131.79M | ||||||||||||
| Water Segment Revenue | $155.72M | $168.15M | $185.11M | $201.15M | ||||||||||||
| Water | — | — | — | — | ||||||||||||
| Other Segment Revenue | — | — | — | — | ||||||||||||
| Other | — | — | — | — | ||||||||||||
| Cag/Lpd Segment Transition | — | — | — | — | ||||||||||||
| Total | $1.46B | $1.57B | $1.64B | $1.83B |
In fiscal 2025, which ended December 31, 2025, the 3 segments Idexx Laboratories Inc /De reported in this breakdown added up to $1.83B. That is less than the $4.30B in its breakdown by segment, so these segments do not account for all of its revenue that year. Cag was the largest segment, at $1.50B or 81.8% of the total, followed by Water Segment Revenue ($201.15M, 11.0%) and Lpd ($131.79M, 7.2%). Together, the two largest segments made up 92.8% of this total.
Compared with fiscal 2024, Cag grew the fastest, rising 12.0% to $1.50B. Every sizeable segment reported in both years grew.
The table also keeps 6 segments that Idexx Laboratories Inc /De no longer reports, so earlier years can still be read on their original basis; use "Show 6 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2010 to 2025, as reported in Idexx Laboratories Inc /De's annual filings.
Idexx Laboratories Inc /De (IDXX) breaks its revenue down by region and segment. In fiscal 2009, its largest region was Asia Pacific Region, with $116.95M or 61.0% of the total, followed by Europe, The Middle East & Africa at $62.48M (32.6%).
Asia Pacific Region was Idexx Laboratories Inc /De's largest region in fiscal 2009, with $116.95M in revenue, 61.0% of the $191.85M reported across its 3 regions.
Idexx Vetlab Consumables was Idexx Laboratories Inc /De's largest segment in fiscal 2025, with $1.50B in revenue, 34.8% of the $4.30B reported across its 8 segments.
Of the Idexx Laboratories Inc /De segments reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Cag Diagnostics Capital - Instruments grew the fastest, rising 51.8% from $131.93M to $200.21M.
Every figure is taken from Idexx Laboratories Inc /De's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by region covers fiscal 2009 to 2009. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.